Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies.
作者信息
Jiang W G
机构信息
Metastasis andAngiogenesis Research Group, Wales College ofMedicine, Cardiff University, Cardiff,United Kingdom.
出版信息
Curr Oncol. 2007 Apr;14(2):66-9. doi: 10.3747/co.2007.108.
Abstract
摘要
相似文献
1
Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies.
Curr Oncol. 2007 Apr;14(2):66-9. doi: 10.3747/co.2007.108.
2
Growth factor attenuation of IFNgamma-mediated hepatocyte apoptosis requires p21waf-1.
Int J Exp Pathol. 2006 Aug;87(4):275-81. doi: 10.1111/j.1365-2613.2006.00481.x.
3
Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
Hum Pathol. 2009 Apr;40(4):496-504. doi: 10.1016/j.humpath.2008.09.011. Epub 2009 Jan 3.
4
Herbacetin, a constituent of ephedrae herba, suppresses the HGF-induced motility of human breast cancer MDA-MB-231 cells by inhibiting c-Met and Akt phosphorylation.
Planta Med. 2013 Nov;79(16):1525-30. doi: 10.1055/s-0033-1350899. Epub 2013 Sep 30.
5
Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs.
Int J Cancer. 2011 Sep 15;129(6):1410-6. doi: 10.1002/ijc.25799. Epub 2011 Feb 26.
6
Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.
Gut. 2012 Aug;61(8):1209-18. doi: 10.1136/gutjnl-2011-301345. Epub 2012 Jan 27.
7
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.
Tumour Biol. 2017 Jun;39(6):1010428317705509. doi: 10.1177/1010428317705509.
8
The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes.
Biochim Biophys Acta. 2013 Dec;1833(12):3286-3294. doi: 10.1016/j.bbamcr.2013.10.004. Epub 2013 Oct 12.
9
The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
Dig Liver Dis. 2006 Jul;38(7):490-7. doi: 10.1016/j.dld.2006.03.007. Epub 2006 Apr 14.
10
Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea.
Invest Ophthalmol Vis Sci. 1996 Apr;37(5):727-39.
引用本文的文献
1
Aptamer-based search for correlates of plasma and serum water T: implications for early metabolic dysregulation and metabolic syndrome.
Biomark Res. 2018 Sep 17;6:28. doi: 10.1186/s40364-018-0143-x. eCollection 2018.
2
Effects of microRNA-29a on retinopathy of prematurity by targeting AGT in a mouse model.
Am J Transl Res. 2017 Feb 15;9(2):791-801. eCollection 2017.
3
The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development.
Cancer Manag Res. 2012;4:183-93. doi: 10.2147/CMAR.S32839. Epub 2012 Jul 25.
本文引用的文献
1
A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth.
Oncogene. 2007 Feb 15;26(7):1078-87. doi: 10.1038/sj.onc.1209859. Epub 2006 Sep 4.
2
Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways.
Cancer Res. 2006 Sep 1;66(17):8687-97. doi: 10.1158/0008-5472.CAN-05-2294.
3
Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.
Cancer Lett. 2007 Apr 18;248(2):219-28. doi: 10.1016/j.canlet.2006.07.007. Epub 2006 Sep 1.
4
Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells.
Mol Cancer Ther. 2006 Jul;5(7):1676-82. doi: 10.1158/1535-7163.MCT-05-0175.
5
c-Met ectodomain shedding rate correlates with malignant potential.
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4154-62. doi: 10.1158/1078-0432.CCR-06-0250.
6
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.
J Clin Invest. 2006 Jun;116(6):1582-95. doi: 10.1172/JCI27236. Epub 2006 May 18.
7
Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions.
Int J Cancer. 2006 Aug 1;119(3):477-83. doi: 10.1002/ijc.21808.
8
A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells.
Oncogene. 2006 May 4;25(19):2773-84. doi: 10.1038/sj.onc.1209306.
9
Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness.
Cancer Res. 2005 Nov 1;65(21):9914-22. doi: 10.1158/0008-5472.CAN-05-1559.
10
Mitogen-inducible gene 6 is an endogenous inhibitor of HGF/Met-induced cell migration and neurite growth.
J Cell Biol. 2005 Oct 24;171(2):337-48. doi: 10.1083/jcb.200502013.
Zotero 插件